Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
67.23 x 12 67.30 x 1
Pre-market by (Cboe BZX)
67.05 -0.82 (-1.21%) 04/16/25 [NASDAQ]
67.23 x 12 67.30 x 1
Pre-market 67.24 +0.19 (+0.28%) 08:11 ET
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
67.32
Day High
68.40
Open 68.10
Previous Close 67.87 67.87
Volume 3,554,500 3,554,500
Avg Vol 6,807,980 6,807,980
Stochastic %K 44.28% 44.28%
Weighted Alpha -7.98 -7.98
5-Day Change +0.29 (+0.43%) +0.29 (+0.43%)
52-Week Range 61.24 - 87.68 61.24 - 87.68
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 207,936,416
  • Shares Outstanding, K 3,101,214
  • Annual Sales, $ 54,073 M
  • Annual Income, $ 7,035 M
  • EBIT $ 10,003 M
  • EBITDA $ 16,691 M
  • 60-Month Beta 0.49
  • Price/Sales 3.89
  • Price/Cash Flow 10.80
  • Price/Book 5.16

Options Overview Details

View History
  • Implied Volatility 35.31% ( +0.92%)
  • Historical Volatility 33.31%
  • IV Percentile 97%
  • IV Rank 61.98%
  • IV High 47.30% on 04/08/25
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 1.22
  • Today's Volume 17,364
  • Volume Avg (30-Day) 8,388
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 187,176
  • Open Int (30-Day) 184,182

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.10
  • Number of Estimates 5
  • High Estimate 1.14
  • Low Estimate 1.05
  • Prior Year 1.03
  • Growth Rate Est. (year over year) +6.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.24 +9.49%
on 04/09/25
Period Open: 77.60
77.76 -13.77%
on 03/17/25
-10.55 (-13.60%)
since 03/14/25
3-Month
61.24 +9.49%
on 04/09/25
Period Open: 66.91
78.36 -14.43%
on 03/05/25
+0.14 (+0.21%)
since 01/16/25
52-Week
61.24 +9.49%
on 04/09/25
Period Open: 68.26
87.68 -23.52%
on 08/30/24
-1.21 (-1.78%)
since 04/16/24

Most Recent Stories

More News
IonQ vs. Rigetti: Which Quantum Computing Stock Is the Better Buy?

These two leading names are vying for supremacy in the fledgling-but-exciting space.

MSFT : 371.61 (-3.66%)
GOOGL : 153.33 (-1.91%)
META : 502.31 (-3.68%)
EADSY : 39.6100 (-0.78%)
SCBFY : 27.3300 (-1.12%)
AZN : 67.05 (-1.21%)
MCO : 425.69 (-2.15%)
IONQ : 24.57 (-3.27%)
RGTI : 8.25 (-4.29%)
AMZN : 174.33 (-2.93%)
HYMTF : 47.1500 (-1.67%)
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis

For Immediate ReleasesChicago, IL – April 14, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

AZN : 67.05 (-1.21%)
NVS : 109.58 (-0.32%)
ABBV : 171.68 (-2.90%)
Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now

A small amount of money can go a long way when it's invested in industry leaders with well-defined catalysts.

COMP : 7.59 (-3.44%)
GOOGL : 153.33 (-1.91%)
GOOG : 155.50 (-2.00%)
$NASX : 16,307.16 (-3.07%)
AZN : 67.05 (-1.21%)
TTD : 48.45 (-1.60%)
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

This week, the European Commission granted marketing authorization to the expanded use of AbbVie’s ABBV Rinvoq and AstraZeneca’s AZN blockbuster cancer drugs, Imfinzi and Daiichi-Sankyo partnered,...

AZN : 67.05 (-1.21%)
NVS : 109.58 (-0.32%)
ABBV : 171.68 (-2.90%)
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs

The stock market was on a roller coaster on April 9 amid the ongoing global trade war triggered by a new series of tariffs by the U.S. government. Most of the pharma bigwigs ended the trading session in...

AZN : 67.05 (-1.21%)
NVO : 62.88 (-2.50%)
LLY : 734.90 (-2.94%)
ABBV : 171.68 (-2.90%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 44.65 (-2.57%)
GOOGL : 153.33 (-1.91%)
MPC : 124.07 (+1.51%)
AAPL : 194.27 (-3.89%)
JNJ : 153.91 (+0.19%)
AMGN : 282.64 (-4.29%)
PFE : 22.04 (-1.78%)
OXY : 38.45 (+1.72%)
TSLA : 241.55 (-4.94%)
FANG : 130.22 (+2.42%)
AMD : 88.29 (-7.35%)
SPY : 525.66 (-2.22%)
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

Might the tariff risk for pharmaceutical stocks be less than you think?

AZN : 67.05 (-1.21%)
LLY : 734.90 (-2.94%)
RHHBY : 38.5800 (+0.21%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 44.65 (-2.57%)
GOOGL : 153.33 (-1.91%)
MPC : 124.07 (+1.51%)
AAPL : 194.27 (-3.89%)
ADI : 175.93 (-2.01%)
JNJ : 153.91 (+0.19%)
AMGN : 282.64 (-4.29%)
PFE : 22.04 (-1.78%)
OXY : 38.45 (+1.72%)
TSLA : 241.55 (-4.94%)
FANG : 130.22 (+2.42%)
AMD : 88.29 (-7.35%)
3 No-Brainer Growth Stocks to Buy for Less Than $100

Don't let the sell-off in the markets scare you off: Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many great stocks you can buy...

ANET : 71.87 (-1.82%)
AZN : 67.05 (-1.21%)
UBER : 73.06 (-1.30%)
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) and the expanded...

AZN : 67.05 (-1.21%)
JNJ : 153.91 (+0.19%)
NVS : 109.58 (-0.32%)
PFE : 22.04 (-1.78%)
SNY : 50.56 (-0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 69.24
2nd Resistance Point 68.70
1st Resistance Point 67.88
Last Price 67.05
1st Support Level 66.52
2nd Support Level 65.98
3rd Support Level 65.16

See More

52-Week High 87.68
Fibonacci 61.8% 77.58
Fibonacci 50% 74.46
Fibonacci 38.2% 71.34
Last Price 67.05
52-Week Low 61.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro